Last reviewed · How we verify
ORPHENADRINE HYDROCHLORIDE
At a glance
| Generic name | ORPHENADRINE HYDROCHLORIDE |
|---|---|
| Modality | Small molecule |
| Phase | FDA-approved |
| First approval | 1957 |
Approved indications
Common side effects
Key clinical trials
- Effectiveness of Chlorzoxazone Versus Orphenadrine Citrate in Alleviating Bruxism Pain (PHASE4)
- Clinical Response of Nuberol Forte in Chronic Neck Pain in Routine Rehabilitation Centers
- Efficiency and Safety a Fixed Combination of Orphenadrine and Diclofenac for Postoperative Analgesia (NA)
- Neodolpasse® Infusion Solution Versus Diclofenac 75 mg Infusion in the Treatment of Postoperative Pain After Elective Knee Surgery (PHASE4)
- Multi-Modal Anesthesia Protocol in Pain Management of Patients Undergoing Posterior Lumbar Spinal Fusion Surgery (PHASE4)
- Orphenadrine Versus Baclofen in Treatment of Muscle Cramps in Cirrhotic Patients (NA)
- Safety & Efficacy of Nuberol Forte® in Pain Management
- Comparison of Post-Operative Analgesia After Percutaneous Nephrolithotomy. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- ORPHENADRINE HYDROCHLORIDE CI brief — competitive landscape report
- ORPHENADRINE HYDROCHLORIDE updates RSS · CI watch RSS